Acetylcholine and noradrenaline enhance foraging optimality in humans.
cognitive enhancers
exploration
marginal value theorem
stay-or-switch
value-based decision-making
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
05 09 2023
05 09 2023
Historique:
pmc-release:
28
02
2024
medline:
31
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Foraging theory prescribes when optimal foragers should leave the current option for more rewarding alternatives. Actual foragers often exploit options longer than prescribed by the theory, but it is unclear how this foraging suboptimality arises. We investigated whether the upregulation of cholinergic, noradrenergic, and dopaminergic systems increases foraging optimality. In a double-blind, between-subject design, participants (N = 160) received placebo, the nicotinic acetylcholine receptor agonist
Identifiants
pubmed: 37639601
doi: 10.1073/pnas.2305596120
pmc: PMC10483619
doi:
Substances chimiques
Acetylcholine
N9YNS0M02X
Methylphenidate
207ZZ9QZ49
Nicotine
6M3C89ZY6R
Norepinephrine
X4W3ENH1CV
Reboxetine
947S0YZ36I
Banques de données
ClinicalTrials.gov
['NCT04384562']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2305596120Références
Neuropsychopharmacology. 2013 Jul;38(8):1495-503
pubmed: 23419875
Biol Psychiatry. 2006 Nov 15;60(10):1111-20
pubmed: 16806100
Science. 2012 Apr 6;336(6077):95-8
pubmed: 22491854
Am J Psychiatry. 2011 May;168(5):540-9
pubmed: 21362742
Elife. 2021 Jan 04;10:
pubmed: 33393461
Psychopharmacology (Berl). 2015 Dec;232(23):4317-23
pubmed: 26349753
Neural Plast. 2017;2017:6031478
pubmed: 28596922
J Cogn Neurosci. 2017 Apr;29(4):652-663
pubmed: 27779907
Exp Clin Psychopharmacol. 2013 Feb;21(1):66-73
pubmed: 23245198
Biol Psychiatry. 2008 Jun 1;63(11):1061-5
pubmed: 17976537
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5466-70
pubmed: 11344295
Psychopharmacology (Berl). 2018 Sep;235(9):2687-2702
pubmed: 29998349
Psychopharmacology (Berl). 2004 Apr;173(1-2):49-56
pubmed: 14668975
J Pharmacol Exp Ther. 1994 Aug;270(2):628-38
pubmed: 8071855
Behav Neurosci. 2015 Oct;129(5):656-665
pubmed: 26191945
Brain Imaging Behav. 2021 Oct;15(5):2593-2605
pubmed: 33675460
Prog Neurobiol. 2004 Dec;74(6):363-96
pubmed: 15649582
Nat Commun. 2021 Nov 26;12(1):6945
pubmed: 34836948
Am J Psychiatry. 2004 Jul;161(7):1173-80
pubmed: 15229048
Am J Psychiatry. 1997 Jan;154(1):50-5
pubmed: 8988958
Neuroimage. 2003 Jul;19(3):1002-13
pubmed: 12880828
J Gerontol B Psychol Sci Soc Sci. 2021 Sep 13;76(Suppl 2):S135-S144
pubmed: 34515772
J Gerontol B Psychol Sci Soc Sci. 2009 Jun;64(4):474-81
pubmed: 19483182
Annu Rev Psychol. 2016;67:641-66
pubmed: 26393872
Trends Ecol Evol. 2022 Nov;37(11):942-952
pubmed: 35842325
Appetite. 2021 Sep 1;164:105260
pubmed: 33848592
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Elife. 2020 Jun 02;9:
pubmed: 32484779
Nat Neurosci. 2010 Apr;13(4):475-81
pubmed: 20208527
Annu Rev Neurosci. 2009;32:95-126
pubmed: 19400722
Psychopharmacology (Berl). 1998 Nov;140(2):135-41
pubmed: 9860103
PLoS One. 2017 Apr 26;12(4):e0176034
pubmed: 28445519
Int J Neuropsychopharmacol. 2013 Aug;16(7):1473-81
pubmed: 23399382
Mol Psychiatry. 2022 Mar;27(3):1573-1587
pubmed: 34725456
J Neurosci. 2019 Feb 20;39(8):1436-1444
pubmed: 30530859
JAMA Psychiatry. 2014 Oct;71(10):1165-73
pubmed: 25142296
Science. 2005 Mar 11;307(5715):1642-5
pubmed: 15761155
Trends Cogn Sci. 2008 Jan;12(1):31-40
pubmed: 18069045
Biochem Pharmacol. 2013 Jun 15;85(12):1713-20
pubmed: 23628449
Neuroimage. 2006 Feb 1;29(3):977-83
pubmed: 16153860
Acta Psychol (Amst). 1983 Apr;53(1):1-8
pubmed: 6869044
Trends Cogn Sci. 2011 Jan;15(1):28-36
pubmed: 21146447
Nat Rev Neurosci. 2018 Jul;19(7):419-427
pubmed: 29752468
Neuropsychopharmacology. 2004 May;29(5):891-900
pubmed: 14970827
Eur J Pharmacol. 1987 Sep 23;141(3):395-9
pubmed: 3666033
Neuropsychopharmacology. 2017 Sep;42(10):1931-1939
pubmed: 28553839
Prog Mol Biol Transl Sci. 2014;122:233-61
pubmed: 24484704
Nebr Symp Motiv. 2017;64:163-199
pubmed: 30351563
Psychopharmacology (Berl). 2012 May;221(1):27-38
pubmed: 22038536
Acta Physiol Scand. 1986 Nov;128(3):351-8
pubmed: 3788613
Nat Hum Behav. 2020 Aug;4(8):832-843
pubmed: 32393840
Front Behav Neurosci. 2009 Sep 07;3:13
pubmed: 19826615
Psychopharmacology (Berl). 2010 Jul;210(4):453-69
pubmed: 20414766
Psychopharmacology (Berl). 2009 Jan;202(1-3):505-19
pubmed: 18604598
Cogn Affect Behav Neurosci. 2015 Dec;15(4):837-53
pubmed: 25917000
Psychopharmacology (Berl). 2007 Apr;191(3):507-20
pubmed: 17031711
PLoS One. 2014 Oct 29;9(10):e111580
pubmed: 25353339
Neuron. 2005 May 19;46(4):681-92
pubmed: 15944135
Sci Rep. 2023 Jan 20;13(1):1126
pubmed: 36670132
Curr Neuropharmacol. 2018;16(4):403-414
pubmed: 29110618
Chest. 1995 Aug;108(2):447-51
pubmed: 7634882
J Neurosci. 2017 Jun 28;37(26):6200-6213
pubmed: 28546312
Cognition. 2013 Dec;129(3):563-8
pubmed: 24055832
JAMA Psychiatry. 2017 Jun 1;74(6):632-640
pubmed: 28403383
Drugs. 2002;62(15):2251-9; discussion 2260-1
pubmed: 12381228
Lancet. 2017 Jul 8;390(10090):156-168
pubmed: 28077234
Biol Psychiatry. 2005 Jun 1;57(11):1410-5
pubmed: 15950015
Science. 2003 Mar 21;299(5614):1898-902
pubmed: 12649484
Trends Cogn Sci. 2015 Nov;19(11):700-710
pubmed: 26483151
Eur Neuropsychopharmacol. 1997 Apr;7 Suppl 1:S23-35; discussion S71-3
pubmed: 9169308
Arch Gen Psychiatry. 2009 Apr;66(4):431-41
pubmed: 19349313
Prog Neuropsychopharmacol Biol Psychiatry. 1992 Mar;16(2):181-91
pubmed: 1579636
J R Soc Interface. 2021 Jul;18(180):20210337
pubmed: 34255987
Front Hum Neurosci. 2010 Aug 26;4:170
pubmed: 21206527
Neuropsychopharmacology. 2022 Jan;47(1):309-328
pubmed: 34312496
Acta Pharmacol Toxicol (Copenh). 1981 Jan;48(1):53-60
pubmed: 6939299
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
Annu Rev Neurosci. 2005;28:403-50
pubmed: 16022602
Theor Popul Biol. 1976 Apr;9(2):129-36
pubmed: 1273796
Nat Neurosci. 2014 Sep;17(9):1249-54
pubmed: 25064851
Biol Psychiatry. 2011 May 1;69(9):902-4
pubmed: 21193172
Psychopharmacology (Berl). 2012 Mar;220(2):331-40
pubmed: 21969123
Neuroscientist. 2008 Aug;14(4):381-95
pubmed: 18660464
J Neurosci. 2017 Jun 7;37(23):5681-5689
pubmed: 28483979
Cogn Affect Behav Neurosci. 2019 Apr;19(2):225-230
pubmed: 30607832
Science. 1997 Mar 14;275(5306):1593-9
pubmed: 9054347
Int J Neuropsychopharmacol. 2014 Jun;17(6):961-77
pubmed: 24423151
Nat Commun. 2022 Aug 4;13(1):4542
pubmed: 35927257
Behav Neurosci. 2022 Oct;136(5):467-478
pubmed: 35834190
Nat Commun. 2019 Mar 29;10(1):1419
pubmed: 30926790
Cogn Affect Behav Neurosci. 2017 Dec;17(6):1073-1083
pubmed: 28900892
NPJ Schizophr. 2021 Feb 3;7(1):6
pubmed: 33536449
J Neurosci. 2020 Jul 1;40(27):5273-5282
pubmed: 32457071
Neuropsychopharmacology. 2006 Jun;31(6):1203-11
pubmed: 16192981